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Abstract 
Mycobacterium tuberculosis (MTB), the main causative organism of tuberculosis (TB), is a successful pathogen that overcomes 
the numerous challenges presented by the immune system of the host. The situation regarding control of tuberculosis has 
significantly worsened over the last decade with the spread of strains resistant to multiple antimycobacterial agents. 
Mycobacterial cell wall has potential as a target for developing protein therapeutic enzybiotic to overcome resistancy case in TB. 
One of the compiler of mycobacterial cell wall is arabinogalactan which is compiled by arabinose with unusual stereochemical. 
Į-L-arabinofuranosidase (Abfa) is an enzyme that can breakdown arabinofuranosidic bond. However, its ability to breakdown the 
arabinofuranosidic from D-arabinose as monomer is still unknown. Here we present protein engineering through computational 
design to improve the specificity of Abfa by replacing discriminate amino acid residue. The effort is done to analyze the ability 
of Abfa in hydrolyzed mycobacterial cell wall and also to analyze the anti-TB assay of Abfa. 
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Nomenclature 
MTB Mycobacterium tuberculosis 
TB tuberculosis 
LAM  lipoarabinomannan   
MA   mycolic acids  
AG  arabinogalactan  
PG peptidoglycan 
D-Araf D-arabinofuranose 
D-Galf D-galactofuranose 
Abfa Į-L-arabinofuranosidase enzyme 
pNPA p-nitrophenyl-L-arabinofuranoside 
H37Rv Mycobacterium H37Rv 
BFCC Mycobacterium sp 
W298R constructed mutant 
1. Introduction 
Mycobacterial diseases such as tuberculosis and leprosy still represent a severe public health problem. For 
instance, the recent emergence of multidrug-resistant tuberculosis strains and, more recently, extensively drug-
resistant tuberculosis clinical isolates has prompted the need for new drugs and drug targets. The causative agent of 
these diseases, Mycobacterium tuberculosis and Mycobacterium leprae, respectively, are characterized by an 
intricate cell envelope. This characteristic mycobacterial cell envelope is composed of four macromolecules, 
lipoarabinomannan (LAM), mycolic acids (MA), arabinogalactan (AG), and peptidoglycan (PG)1. The arabinans and 
galactans of mycobacterial cell walls consist of D-arabinofuranose (D-Araf) and D-galactofuranose (D-Galf). 
Hydrolyzing these sugars can potentially be useful for new chemoteraupetic drug development for anti 
mycobacterium such as Mycobacterium leprae, Mycobacterium tuberculosis, Mycobacterium avium, Mycobacterium 
smegmatis, etc2.  
Endogenous mycobacterial endo-D-arabinase activity, which degrades cell wall polysaccharide arabinogalactan, 
was found in Mycobacterium smegmatis. The arabinan product contains 20-30 arabinosyl residues but no 
galactofuranosyl residues. Recognition of this endogenous activity results in the possibility of developing antileprosy 
and antituberculosis drugs that do not require bacterial growth for activity3. 
Alpha-L-arabinofuranosidase enzyme (EC.3.2.1.55) can hydrolyze non-reduction end between Į-L-
arabinofuranosidase lingkage with other polysaccharide which contain arabinofuranose4. This enzyme is part of 
hydrolase glycoside which has a role in degradation process of hemicelluloses arabinoxylan, arabinogalactan and L-
arabinan. The Į-L-arabinofuranosidase enzyme (Abfa) from a thermophilic bacterium Geobacillus thermoleovorans 
IT-08, which had been isolated from Gunung Pancar hotspring (Bogor, Indonesia), was successfully cloned into the 
plasmid pTP510 in Escherichia coli DH5Į5. This gene cluster is encoded in data Gene bank as Į-L-
arabinofuranosidase (DQ387046) (Puspaningsih, 2005). The Į-L-arabinofuranosidase gene has been subcloned into 
the pET101/D-TOPO expression vector resulting in pET-abfa, and it can be overexpressed in E. coli BL21 (DE3)6.           
We show here that (1) the strategic of protein engineering to improve the specificity of Abfa by computational 
design based on interactive fingerprint identification, (2) the ability of Abfa to hydrolyze D-arabinose as constituent 
of Mycobacterial cell wall that has not been reported, and (3) the ability of Abfa as anti-TB candidate. This research 
adds the prospect to develop bio-product enzybiotic based on the cell wall degrading enzyme as anti-TB to overcome 
the Mycobacterial resistance case.  
2. Methods 
2.1. Computational protein design and site-directed mutagenesis  
 
Amino acid sequence of Į-L-arabinofuranosidase was obtained from National Center of Biotechnology 
Information, which is used to identify the conserved amino acid. Model structure of Abfa was obtained from Protein 
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Modeling Data Base, access code PM0078180 and Į-L-arabinofuranosidase GH51 was obtained from Protein Data 
Bank, access code 1QW9. Bioinformatic analysis was performed using MEGA5, AutoDock4, PyMol, ConSurv 
server, and PDBsum to predict the site of amino acid as substrate discriminate. Tryptophan number 298 (Trp298) 
was chosen as target for site-directed mutagenesis. Mutagenic primers were designed according to amino acid 
sequence of Abfa. The mutagenic primers that were used to create point mutations were fW298R 5’-
GAATGGAACGTAAGGTACC ACTCGAATG-3’ and rW298R 5’-CATTCGAGTGGTACCTTACGTTCCATTC-
3’. Site-directed mutagenesis was performed on pET-abfa construct following template by PCR using Quick-Change 
II XL according to manufacturer’s protocol. Mutated amplification products were transformed into E. coli TOP10 
and E. coli BL21. Mutant W298R was confirmed by DNA sequencing analysis.  
 
2.2. Production and purification Į-L-arabinofuranosidase 
 
Alpha-L-arabinofuranosidase from Abfa and W298R were obtained from isolated inoculation into LB medium 
with adding ampicillin (100 mg mL-1) and harvested after 18 hours incubation. The cell pellet were re-suspended 
into buffer purification and disrupted by ultrasonicator (2 x 2 minutes). Cell debris was removed by centrifugator at 
3,500 rpm for 15 minutes at 4°C. The supernatant was heated using water incubator at 70°C for 1 hour and 
centrifuged to obtain heating fraction. Protein purification was performed using gradient immidazol by Fast-Protein 
Liquid Chromatography IMAC column and confirmed by SDS-Page analysis. This purified protein was used for 
specific activity assay, cell wall hydrolysis and anti-tuberculosis test. 
 
2.3. Alpha-L-arabinofuranosidase assay 
 
Alpha-L-arabinofuranosidase activity was determined by measuring the amount of p-nitrophenol released from p-
nitrophenil-L-arabinofuranoside (pNPA) as substrate at pH 6. The reaction was performed with formula contained 
180 μL of 1 mM pNPA and 20 μL of enzyme solution. The mixture was incubated at 70°C for 10 minutes and 
reaction was stopped by addition of 600 mL Na2CO3 1 M. The amounts p-nitrophenol released was measured by 
monitoring its absorbance at 410 nm and interpolated in p-nitrophenol standard curve. One unit activity of Į-L-
arabinofuranosidase was defined as the amount of enzyme producing 1 μmol of p-nitrophenol in 1 minute under the 
assay condition. The specific activity of enzyme was determined by unit activity of enzyme per milligram of total 
protein. 
 
2.4. Preparation and hydrolysis of mycobacterial cell wall 
 
Mycobacterium H37Rv cell (H37Rv) and Mycobacterium sp (BFCC) isolate was obtained from TB Vaccine 
Testing and Research Material Contract Colorado State University and Biofarma Culture Collection, respectively. 
H37Rv isolate was grown 21 days in Middlebrook 7H9-Dextrose broth + 0.05% Tween 80 according to difco 
manual. Mycolil-arabinogalactan peptidoglycan from Mycobacterial was obtained as described previously7 except 
without proteinase-K treatment. Cell wall fraction was confirmed using mild hydrolysis as described previously8 and 
hydrolysis products were analyzed by High Performance Liquid Chromatography.   
 
2.5. Anti-tuberculosis test 
 
Anti-tuberculosis testing was performed as described previously9. Mycobacterium sp BFCC was used in the anti-
TB test using Resazurin redox assay. Culture was grown in 7H9 broth for 7-10 days and then diluted to an optical 
density of McFarland Standard No.1 with the cells density 108 CFU mL-1 approximately. Abfa (50, 100, 200 U.mg-1) 
alone and combination with rifampicin were used. Positive control was added with rifampicin (0.25; 0.5; 1.0 and 1.5 
μg.mL-1) as antibiotic and negative control consisted of bacteria and reagents only. Anti-TB assay was performed 
with formula containing 900 μL of 7H9 broth and 100 μL of Resazurin (0.1%). Blue color in the well was 
interpreted as no growth, and pink color was scored as growth. 
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3. Results and Discussion 
 
Protein engineering aimed at improving the enzymes specificity to hydrolyze the substrate can be done by rational 
computational design10. Rational computational design is carried out using bioinformatic data and computational 
simulation. Protein computational design has been done in this research to improve the specificity of Į-L-
arabinofuranosidase. Į-L-arabinofuranosidase from Geobacillus thermoleovorans IT-08 is a group of glycoside 
hydrolase family 51 that has a catalytic domain (ȕ/Į)8 and two catalytic Glu residues which serve as a proton donor 
and a nucleophile/base11. To get the protein design that has a broader specificity, the strategy used in this study is to 
replace the enzyme specificity determining residues. Bioinformatic analysis has been done to get that point through 
interactional fingerprint identification. The results of multiple-sequence alignment of 49 Į-L-arabinofuranosidase 
GH51 amino acid show that the results are as expected: the catalytic residues Glu175 and Glu294 including 
conserved residues. However, there is a conserved amino acid residue besides the catalytic residues which forms a 
gap (Fig. 1a). Among the amino acid residues is an amino acid residue thought to have a role in substrate 
discrimination. Analysis of the interactional fingerprint of 5 enzyme-substrate complex structure of PDB (Protein 
Data Base) using PyMol and PDBsum shows that there is a binding mode conserve subs site -1. Binding mode 
conserve is formed by two kinds of interactions, namely hydrogen interaction (Glu29, Asn74, Tyr246 and Glu294) 
and hydrophobic interaction (Gly73, Trp99 and Trp298) (Fig. 1b). 
 
 
 
 
Fig. 1.  Model structure of Abfa, (a) shows the conserve region of Abfa. The amino-acids and the nucleotides are colored by their conservation 
grades using the color-coding bar, with turquoise-through-maroon indicating variable-through-conserved; (b) shows the binding mode of Abfa 
with its substrate. The interactions shown are those mediated by hydrogen bonds (green) and by hydrophobic contacts (orange). 
 
Interaction of hydrogen that is formed has the function to stabilize the binding force of arabinofuranosyl during 
the catalytic reaction12. Therefore, the amino acid residue that forms the hydrophobic interaction is suspected as a 
determinant of substrate specificity of GH51 Abfa. This conjecture agrees with previous reports12 in which amino 
acid residue that is not present in the cellulase enzyme appears in a group of arabinofuranosidase enzymes, the 
Trp298 (Fig. 2). In confidence, Trp298 residue is determined as the target in this study to enhance the Abfa 
specificity. Trp298 is a type of amino acid which is non-polar, so we replaced it with polar residue, namely Arg 
which can eliminate the effects of steric hindrance and does not drastically change the active side. 
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Fig. 2. Superimpose of AbfA and Cel512 
 
Constructed mutant (W298R) has been confirmed by DNA sequencing analysis and over-expression of the 
transformed pET-W298R into the host cell E. coli BL21 (DE3). The result using one-step purification was 
confirmed using SDS-Page analysis showing the tape measure ± 59 kDa and increased purity level shown in the 
purification table (Table 1). The results indicate that the determination of the Abfa activity has a specific activity of 
16.7 times higher than W298R. As expected, mutation in Trp298 affects the catalytic activity of the enzyme but not 
drastically when compared with Glu29 [12]. This result is very reasonable because the point mutation occurs in the 
active enzyme. Mutations were designed not to show an increase in substrate specificity, but these results 
demonstrate the potential of Trp298 as a mutation target point, replacing it with polar amino acid residues other than 
Arg.  
 
Table 1. Purification of Abfa and W298R 
Sample Unit activity (U mL-1) 
Protein content 
 (mg mL-1) 
Specific   activity 
(U mg-1) Purification (times) 
Abfa 
Crude 7.186 0.423 16.967 1 
Purified 4.119 0.017 247.966 14.61 
W298R 
Crude 2.104 0.181 11.650 1 
Purified 8.667 0.0583 148.66 12.76 
 
Abfa specificity to hydrolyze D-arabinose substrate was determined using arabinogalactan substrate which was 
contained in the mycobacterial cell wall. Isolation and analysis of mycobacterial cell wall extracts have been done in 
this study. HPLC analysis results showed that the isolated cell wall extracts contain arabinose and galactose (Fig. 3). 
It means that the isolation of arabinogalactan from mycobacterial cell wall has been successful.  
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Abfa specificity to hydrolyze mycobacterial cell wall is determined by measuring the amount of arabinose 
(reducing sugar) produced. The results showed that the Abfa specificity on mycobacterial cell wall is lower than the 
plant cell wall substrates (arabinogalactan, arabinan, oat spelt xylan) (Fig. 4a). There are several possible causes for 
differences in the specific activity of Abfa, one of which is a different configuration of the arabinose 
monosaccharide on polysaccharide chain. It is evident from arabinogalactan and arabinan which have differences in 
structure: arabinose as branched-chain groups on arabinogalactan and arabinose as the backbone of the arabinan.  In 
addition, there are also differences in the arabinose stereochemistry of mycobacterial cell wall compiler compared to 
plants. Because synthetic substrates with stereochemical D is not available, then the determination of the kinetics 
specificity cannot be done. However, this study can prove that Abfa have catalytic activity on both the 
stereochemistry arabinose, L-arabinose and D-arabinose, which have not been previously reported. These results 
confirm previous reports that endogenous arabinase (endo type) of putative Cellulomonas and Mycobacterium is 
able to hydrolyze the cell wall of Mycobacteria and produces oligo-arabinose3,13. This study can prove that 
arabinofuranosidase (exo type) EC 3.2.1.55 is able to hydrolyze substrates with stereochemical D arabinose, as 
evidenced by the analysis results of hydrolysis products (Fig. 4b). 
 
 
Fig. 4. Specific activity of Abfa toward substrate, (a) Bar chart specific activity of Abfa;  (b) Chromatogram of hydrolysis product, (A) Standard 
arabinose (RT 0.98 minute), (B) H37Rv-AbfA: (1) arabinose (RT 1.02 menit), (2) polysaccharide (RT 0.295 minute). 
Fig. 3. Hydrolysis product analysis of H37Rv 
cell wall. (A) Arabinose standard (RT 0.98 
minute); (B) Galactose standard (RT 1.742 
minute); (C) H37Rv hydrolysis product 1: 
arabinose (RT 0.957 minute), 2: galactose (RT 
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In this study, we have successfully demonstrated the Abfa ability to hydrolyze substrate D-arabinose which never 
been previously reported. In other words, Abfa is able to hydrolyze the cell wall of Mycobacterium. Abfa’s ability to 
hydrolyze Mycobacteria cell wall creates a prospect of therapeutic protein development as candidate of anti-TB 
based on cell wall degrading enzymes. It has been reported that lysine A and B of Mycobacteriophage lysine has the 
prospect of being anti-TB14. Enzybiotic development based on natural processes that occur in nature, where the 
phage life cycle stages, are stages of cell lysis using lysine A for hydrolysis of peptidoglycan and lysine B for 
hydrolysis mycolil. Development of enzybiotic has a promising prospect to overcome the resistance problems that 
occur in Mycobacterium. To determine the ability of Abfa as a candidate of anti-TB, we are conducting anti-TB 
testing in vitro. 
The anti-TB test used rifampicin as an antibiotic. Rifampicin is used as a positive control. Rifampicin or rifampin 
is a broad-spectrum antibiotic; the most widely used to treat TB is rifamycin. Rifamycin contains an aromatic 
nucleus linked on both sides by an aliphatic bridge. The rifamycin easily diffuse across the M. tuberculosis cell 
membrane due to their lipophilic profile15. Their bactericidal activity has been attributed to their ability to inhibit 
transcription by binding with high affinity to bacterial DNA-dependent RNA polymerase. Although the molecular 
target of rifampin has been well characterized, the precise mechanism by which this interaction leads to 
mycobacterial killing remains unclear16. The anti-TB test (Fig. 5) showed that Abfa alone cannot prevent the growth 
of Mycobacterium. This is due to the growth of Mycobacterium which occurs at a temperature of 37°C, while Abfa 
can work optimally at a temperature of 70°C because Abfa is thermophilic enzyme6. This can be handled with the 
use of Abfa which is able to work optimally at mesophile temperatures in future studies. The combination of Abfa 
and rifampicin can prevent the growth of Mycobacterium. This indicates that the Abfa can work in synergy with 
antibiotics. However, more research is needed about the synergy mechanisms of Abfa-antibiotic and development of 
Abfa in future as enzybiotic, a candidate of anti-TB and other anti-Mycobacterium. 
 
 
Fig. 5. The anti-TB test, (A1) Abfa (100 U.mg-1); (A2): Abfa (200 U.mg-1), (A3) Rifampicin (0.25μg.mL-1 );  (A4) Rifampicin (0.5μg.mL-1), (A5) 
Rifampicin (1.0μg.mL-1), (A6) Rifampicin (1.5μg.mL-1) (A7) A0 (Abfa (50 U.mg-1))+A3, A8: A1+A3; (A9) A2+A3; (A10) control negative 
(bacteria+reagent, no Abfa and rifampicin). Blue : no growth; pink : growth.  B&C : replication 
 
4. Conclusions 
We found that the replacement of Trp298 to Arg298 from design result did not show the improvement of the 
Abfa specific activity. However, this mutation does not lead to significant decrease on its activity. That means we 
are still confident with our design as mutation target point by replacing it with other polar amino acids. We have 
shown the ability of Abfa to hydrolyze D-arabinose as the compiler of Mycobacterial cell wall. The anti-TB test 
showed that combination of Abfa and rifampicin can prevent the growth of Mycobacterium, which indicates that 
Abfa has prospect as anti-TB candidate. 
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